Skip to content

Addiction: all studies

Page 771 of 857: studies 7,701 to 7,710 of 8,563, newest first. Back to the addiction overview

Research

“FALSE POSITIVE” CLAIMS OF NEAR-DEATH EXPERIENCES AND “FALSE NEGATIVE” DENIALS OF NEAR-DEATH EXPERIENCES

Death Studies February 23, 2005 Bruce Greyson 11 citations

Some persons who claim to have had near-death experiences (NDEs) fail research criteria for having had NDEs ("false positives"); others who deny having had NDEs do meet research criteria for having had NDEs ("false negatives"). The author evaluated false positive claims and false negative denials in an organization that promotes near-death research and in psychiatric outpatients. The frequency...

DOI: 10.1080/07481180590906156 (opens in new tab) False positive paradox True positive rate

Cannabis Use in Psychiatrie Patients.

Medical journal, Armed Forces India February 2005 S Chaudhury, S Sudarsanan, S K Salujha et al.

Cannabis abuse has been associated with psychiatric disorders. The pattern of cannabis use and incidence of cannabis dependence and cannabis psychosis among 471 consecutive patients admitted to a tertiary care psychiatric center was investigated. Cannabis use was reported by 67 (14.23%) patients of whom 42 (8.92%) were occasional users, 18 (3.82%) were classified as frequent users while 7...

Pagliaros’ Comprehensive Guide to Drugs and Substances of Abuse

American Journal of Health-System Pharmacy February 1, 2005 Peter J. Zed 1 citation

Drug and substance abuse is a major problem in North America. Health care providers who care for patients who abuse drugs and other substances need to have a clear understanding of the health, societal, and economic impact of this problem and an intimate knowledge of the agents of abuse to ensure adequate treatment. Pagliaros' Comprehensive Guide to Drugs and Substances of Abuse was written to...

FDA Approves Study of Ecstasy In Some Terminally Ill Patients

Psychiatric News January 21, 2005 Eve Bender 4 citations

Back to table of contents Previous article Next article Clinical & Research NewsFull AccessFDA Approves Study of Ecstasy In Some Terminally Ill PatientsEve BenderEve BenderPublished Online:21 Jan 2005https://doi.org/10.1176/pn.40.2.00400046a Can the same drug that in the past decade has found a niche among young people during rave parties at crowded dance clubs also help terminally ill patients...

Ketamine Induces Dopamine-Dependent Depression of Evoked Hippocampal Activity in the Nucleus Accumbens in Freely Moving Rats

Journal of Neuroscience January 12, 2005 Mark J. Hunt, Karima Kessal, Rene Garcia

Noncompetitive NMDA receptor antagonists, such as ketamine, induce a transient schizophrenia-like state in healthy individuals and exacerbate psychosis in schizophrenic patients. In rodents, noncompetitive NMDA receptor antagonists induce a behavioral syndrome that represents an experimentally valid model of schizophrenia. Current experimental evidence has implicated the nucleus accumbens in...

Complex discriminative stimulus properties of (+)lysergic acid diethylamide (LSD) in C57Bl/6J mice

Psychopharmacology January 11, 2005 Michael A. Benneyworth, Randy L Smith, Robert J. Barrett et al. 38 citations

RationaleThe drug discrimination procedure is the most frequently used in vivo model of hallucinogen activity. Historically, most drug discrimination studies have been conducted in the rat. With the development of genetically modified mice, a powerful new tool has become available for investigating the mechanisms of drug-induced behavior. The current paper is part of an ongoing effort to...

Buddhist Phenomenology: A Philosophical Investigation of Yogacara Buddhism and the Ch'eng Wei-shih Lun (review)

Philosophy East and West 2005 Charles Muller

Reviewed by: Buddhist Phenomenology: A Philosophical Investigation of Yogacara Buddhism and the Ch'eng Wei-shih Lun Charles Muller Buddhist Phenomenology: A Philosophical Investigation of Yogacara Buddhism and the Ch'eng Wei-shih Lun. By Dan Lusthaus. Curzon Critical Studies in Buddhism Series. London: Routledge, 2002. Pp. xii + 611. Hardcover $65.00. Western students of Yogācāra Buddhism have...

Biochemical, pharmacological, and toxic effects of n-metil 3,4-methylenedioxyamphetamine - "ecstasy"

Vojnosanitetski Pregled 2005 Zivorad Malicevic, Milica Ninković, Ivana Vasiljević et al.

Navedeni podaci ukazuju da ?ekstazi? nije, kako se to posebno medju omladinom smatra, laka, bezopasna i zabavna droga. Obilje nezeljenih psihickih, neuroloskih, hepatickih, bubreznih, kardiovaskularnih i drugih toksicnih efekata pokazuje samo da oni nisu dobro procenjeni, a najopasnije je sto se desavaju pri upotrebi uobicajenih prosecnih doza ove droge. Uzivaoci u vecini slucajeva prelaze...

The mental self.

Progress in Brain Research 2005 Hans C Lou, Markus Nowak, Troels W Kjaer

In meditation both the quality and the contents of consciousness may be voluntarily changed, making it an obvious target in the quest for the neural correlate of consciousness. Here we present the results of a positron emission tomography study of yoga nidra relaxation meditation when compared with the normal resting conscious state. Meditation is accompanied by a relatively increased perfusion...

NMDA hypofunction in the posterior cingulate as a model for schizophrenia: an exploratory ketamine administration study in fMRI.

Schizophrenia Research January 1, 2005 Georg Northoff, Andre Richter, Felix Bermpohl et al.

Based on animal data, NMDA receptor hypofunction has been suggested as a model for positive symptoms in schizophrenia. NMDA receptor hypofunction affects several corticolimbic brain regions, of which the posterior cingulate seems to be the most sensitive. However, empirical support for a crucial role of posterior cingulate NMDA hypofunction in the pathophysiology of positive symptoms is still...